Botanical Solution Inc. raises $6.1 million in Series A
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
New role strengthens Quantori’s global leadership position in data science & digital IT
APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
The company has 47 ANDA's pending approval with the U.S.FDA
Narayanan to lead SeQuent through next phase of consolidation and growth
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions
Acquisition adds Adaptate’s novel antibody-based ?? T-cell engager platform to Takeda’s Immuno-oncology portfolio built around the Innate Immune System
Subscribe To Our Newsletter & Stay Updated